|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/17 | |||
| A61K 38/20 | |||
| A61P 35/00 | |||
| C07K 16/24 |
| (11) | Patento numeris | 2608808 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11820492.4 |
| Europos patento paraiškos padavimo data | 2011-08-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-07-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-01-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/048747 |
| Data | 2011-08-23 |
| (87) | Numeris | WO 2012/027324 |
| Data | 2012-03-01 |
| (30) | Numeris | Data | Šalis |
| 201161480635 P | 2011-04-29 | US | |
| 376097 P | 2010-08-23 | US | |
| 411183 P | 2010-11-08 | US | |
| 406759 P | 2010-10-26 | US |
| (72) |
SIMARD, John, US
|
| (73) |
XBiotech, Inc,
1055 West Hastings Street, Suite 300, Vancouver, BC V6E 2E9,
CA
|
| (54) | TREATMENT FOR NEOPLASTIC DISEASES |
| TREATMENT FOR NEOPLASTIC DISEASES |